Evidence map›Paper›PMID 24798746›Full record

ArticleClinical genetics2015

Influence of individual differences in disease perception on consumer response to direct-to-consumer genomic testing.

D L Boeldt, N J Schork, E J Topol, C S Bloss

Abstract read
In one paragraph

Article in Clinical genetics, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Trial
  3. Trial
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Paving the way to better population health through personalised nutrition.EFSA journal. European Food Safety Authority · 2019
    Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

D L BoeldtScripps Genomic Medicine, Scripps Translational Science Institute, and Scripps Health, La Jolla, CA, USA.
N J Schork
E J Topol
C S Bloss

Funding

Scripps Translational Science InstituteUL1TR001114 · NCATS · SCRIPPS RESEARCH INSTITUTE, THE · PI TOPOL, ERIC JEFFREY · 2013 to 2017
$24.0M
SCRIPPS TRANSLATIONAL SCIENCE INSTITUTE (UL1)UL1RR025774 · NCRR · SCRIPPS RESEARCH INSTITUTE, THE · PI TOPOL, ERIC JEFFREY · 2008 to 2011
$16.3M
Scripps Translational Science Institute (UL1)UL1TR000109 · NCATS · SCRIPPS RESEARCH INSTITUTE, THE · PI TOPOL, ERIC JEFFREY · 2012 to 2013
$4.0M
Response to Testing Among Individual Consumers of DTC Personal Genomics ServicesR21HG005747 · NHGRI · SCRIPPS HEALTH · PI BLOSS, CINNAMON S · 2010 to 2011
$250k
NCATS NIH HHS 8UL1 TR000109NCATS NIH HHS 8UL1 TR001114NCATS NIH HHS UL1 TR000109NCATS NIH HHS UL1 TR001114NCRR NIH HHS 5UL1RR025774NCRR NIH HHS UL1 RR025774NHGRI NIH HHS 1R21HG005747NHGRI NIH HHS R21 HG005747
6 · The paper itself

Abstract

Individuals who undergo multiplex direct-to-consumer (DTC) genomic testing receive genetic risk results for multiple conditions. To date, research has not investigated the influence of individual differences in disease perceptions among consumers on testing outcomes. A total of 2037 participants received DTC genomic testing and completed baseline and follow-up surveys assessing disease perceptions and health behaviors. Participants were asked to indicate their most feared disease of those tested. Perceived seriousness and controllability of the disease via lifestyle or medical intervention were assessed. Participants most frequently reported heart attack (19.1%) and Alzheimer's disease (18.6%) as their most feared disease. Perceived seriousness and control over the feared disease both influenced response to DTC genomic testing. Greater perceived seriousness and diminished perceived control were associated with higher, but not clinically significant levels of anxiety and distress. In some cases these associations were modified by genetic risk. No significant associations were observed for diet, exercise and screening behaviors. Individual differences in disease perceptions influence psychological outcomes following DTC genomic testing. Higher perceived seriousness may make a consumer more psychologically sensitive to test results and greater perceived control may protect against adverse psychological outcomes. Findings may inform development of educational and counseling services.

Indexed as

Genetic TestingIndividualityPerceptionAdultAgedAged, 80 and overFemaleFollow-Up StudiesGenetic CounselingHealth Knowledge, Attitudes, PracticeHumansMaleMiddle AgedPatient Outcome AssessmentPatient ParticipationRisk Factorsdirect-to-consumerdirect-to-consumer outcomesgenetic testinggenomic risk assessmentHealth Belief Modelpersonalized medicinerisk perceptions

Identifiers

PMID24798746
PMCPMC4758676

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.